Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Colloidal oatmeal + activated oil** is an investigational over-the-counter topical eczema formulation consisting of a standard colloidal-oatmeal skin-protectant preparation amended with GlycosBio's proprietary modified plant-oil technology, termed Activated Oil. In the registered NCT05413395 study, the formulation was applied to mild-to-moderate eczema lesions to assess effects on clinical symptoms and the skin microbiome. Activated Oil is described as a proprietary blend of modified plant oils intended to provide selective antimicrobial activity while preserving commensal skin microorganisms; the exact oil composition and commercial product identity were not publicly disclosed. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05413395))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on colloidal oatmeal + activated oil.